Access cutting-edge lung cancer treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This phase III trial studies how well nivolumab and ipilimumab works with or without local consolidation therapy in treating patients with stage IV non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Local consolidation therapy, such as surgery or radiation therapy, may improve survival outcomes in patients with non-small c
Sponsor: M.D. Anderson Cancer Center
Check if you qualify for this lung cancer clinical trial in Houston, TX
If you're searching for lung cancer treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.